🇺🇸 FDA
Patent

US 11311613

Development of agonist epitopes of the human papillomavirus

granted A61KA61K2239/59A61K39/12

Quick answer

US patent 11311613 (Development of agonist epitopes of the human papillomavirus) held by THE UNITED STATES OF AMERICA, represented by the Secretary, Department of Health and Human Services expires Mon Apr 21 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
THE UNITED STATES OF AMERICA, represented by the Secretary, Department of Health and Human Services
Grant date
Tue Apr 26 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 21 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
25
CPC classes
A61K, A61K2239/59, A61K39/12, A61K40/13, A61K40/19